JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WECHSLER, A. S.
Right arrow Articles by GLICK, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WECHSLER, A. S.
Right arrow Articles by GLICK, G.
Journal of Pharmacology And Experimental Therapeutics, Vol. 170, Issue 1, 62-71, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


MECHANISM OF THE SYMPATHOMIMETIC ACTION OF CYCLOHEXYLAMINE AND HEXYLAMINE: RELEASE OF CATECHOLAMINES FROM NERVE ENDINGS

ANDREW S. WECHSLER 1, STEPHEN E. EPSTEIN 1, and GERALD GLICK 1

1 Cardiology Branch, National Heart Institute, National Institutes of Health, Bethesda, Maryland

The sympathomimetic effects of cyclohexylamine, a six-carbon cyclic aliphatic amine, and hexylamine, a six-carbon straight-chain aliphatic amine, were studied in open-chest dogs with an intact circulation, in dogs on cardiopulmonary bypass and in the isolated, perfused canine hindlimb. Both drugs produced dose-dependent augmentation of left ventricular dp/dt, right ventricular contractile force, heart rate and systemic arterial pressure. Depletion of endogenous catecholamine stores by reserpine or blockade of the neural uptake mechanism by cocaine abolished or significantly lessened these positive responses to both cyclohexylamine and hexylamine. It is concluded, therefore, that these two simple amines exert their sympathomimetic effects on the cardiovascular system indirectly, by causing the release of neuronally stored catecholamines. The observation that cyclohexylamine has such cardiovascular effects is of particular interest since it is the principal excreted metabolite of cyclamate, a chemical widely employed as a non-nutritive sweetening agent. However, cyclamate administered i.v. does not appear to affect the cardiovascular system.

Submitted on April 2, 1969
Accepted on June 26, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.